InvestorsHub Logo
Followers 3
Posts 80
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Thursday, 08/18/2022 6:06:24 AM

Thursday, August 18, 2022 6:06:24 AM

Post# of 1454
Building higher support level broke the 50 day moving average

Imo ONCT in negotiations with AbbVie

Deals take time

Data was excellent. Doubled CR of ibrutinib alone in MCL (ibrutinib ) close to 10 billion in sales annually

Data in P53 mutant CCL is game changing

AbbVie collaborated on trial design

Agreed to provide ~$5M per month in ibrutinib for P3 trial

Recent options awards contained clause in case of change in control


Insiders Buying at these levels.


https://www.oncternal.com/pipeline
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News